Leonid Beigelman SEC EDGAR Filings (CIK 0001824721)

SEC EDGAR filings, ownership reports, and insider transactions for Leonid Beigelman.

Business address
C/O Aligos Therapeutics, Inc., One Corporate Drive, 2 Nd Floor, South San Francisco, CA, 94080
Get insider transactions for this reporting owner
Leonid Beigelman has filed 8 SEC EDGAR filings since 15 Oct 2020

Latest Filings

Recent SEC filings for Leonid Beigelman including 4, SC 13G/A, SC 13G and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 17 Mar 2023 15 Mar 2023 001-39617
4 Open 4 document View SEC filing for 4 FORM 4 11 Jul 2022 07 Jul 2022 001-39617
SC 13G/A Open SC 13G/A document View SEC filing for SC 13G/A SC 13G/A 10 Feb 2022
4 Open 4 document View SEC filing for 4 FORM 4 08 Feb 2022 04 Feb 2022 001-39617
SC 13G Open SC 13G document View SEC filing for SC 13G SC 13G 11 Feb 2021
4 Open 4 document View SEC filing for 4 FORM 4 03 Dec 2020 01 Dec 2020 001-39617
4 Open 4 document View SEC filing for 4 FORM 4 20 Oct 2020 20 Oct 2020 001-39617
3 Open 3 document View SEC filing for 3 FORM 3 15 Oct 2020 15 Oct 2020 001-39617

About this filer

Leonid Beigelman files with the SEC under CIK 0001824721. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages